We are live on
!
Find out more
DC
Diametric Capital Portfolio holdings
AUM
$385M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
-1.96%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
–
AUM
$385M
AUM Growth
+$11.7M
(+3.1%)
Cap. Flow
+$39.6M
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
618
New
251
Increased
83
Reduced
136
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$12.1M |
| 2 |
FPS
Forgent Power Solutions
FPS
|
+$4.81M |
| 3 |
PENN Entertainment
PENN
|
+$4.5M |
| 4 |
Flutter Entertainment
FLUT
|
+$3.99M |
| 5 |
A2Z Smart Technologies
AZ
|
+$3.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harrow
HROW
|
+$7.36M |
| 2 |
Red Rock Resorts
RRR
|
+$5.36M |
| 3 |
AIFC
AI Financial Corp
AIFC
|
+$5.22M |
| 4 |
Warner Bros
WBD
|
+$3.2M |
| 5 |
MGM Resorts International
MGM
|
+$2.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.21% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Technology | 14.08% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Achieve Life Sciences
ACHV
$648M
| $54.8K | 0.01% |
+18,651
| New | +$82.8K |
|
452
Sagimet Biosciences
SGMT
$435M
| $52.5K | 0.01% |
+10,043
| New | +$56K |
|
453
Galectin Therapeutics
GALT
$230M
| $47.7K | 0.01% |
+17,089
| New | +$52K |
|
454
Apyx Medical
APYX
$165M
| $47.4K | 0.01% |
+12,833
| New | +$48K |
|
|
BNC
455
CEA Industries
BNC
$121M
| $43.1K | 0.01% |
+14,768
| New | +$65.1K |
|
456
Inovio Pharmaceuticals
INO
$87.2M
| $42.6K | 0.01% |
+24,491
| New | +$40.3K |
|
457
Prelude Therapeutics
PRLD
$312M
| $41K | 0.01% |
+11,980
| New | +$31.4K |
|
458
Playboy Inc
PLBY
$147M
| $37K | 0.01% |
+24,365
| New | +$44.5K |
|
459
Rekor Systems
REKR
$84.6M
| $36.6K | 0.01% |
+44,651
| New | +$47.8K |
|
|
BBBY.WS
460
Bed Bath & Beyond Warrants
BBBY.WS
| $34.6K | 0.01% |
61,658
-1,020
| -2% | -$724 |
|
|
SUIG
461
Sui Group Holdings
SUIG
$90.6M
| $33.2K | 0.01% |
+27,418
| New | +$40.6K |
|
462
GoPro
GPRO
$128M
| $32.9K | 0.01% |
+42,726
| New | +$43K |
|
463
Black Diamond Therapeutics
BDTX
$105M
| $32.8K | 0.01% |
+15,386
| New | +$36.6K |
|
464
MDxHealth
MDXH
$22.4M
| $30.4K | 0.01% |
+13,203
| New | +$44.8K |
|
465
Genelux
GNLX
$133M
| $29.4K | 0.01% |
+12,150
| New | +$33.1K |
|
466
PepGen
PEPG
$133M
| $26.9K | 0.01% |
+15,221
| New | +$85.5K |
|
|
TRON
467
Tron Inc
TRON
$726M
| $25.9K | 0.01% |
+11,422
| New | +$18K |
|
468
Rani Therapeutics
RANI
$101M
| $24.4K | 0.01% |
+33,208
| New | +$42.4K |
|
469
Roadzen
RDZN
$96.4M
| $20.1K | 0.01% |
+16,781
| New | +$25.6K |
|
470
BTCS Inc
BTCS
$52.3M
| $18.9K | ﹤0.01% |
+13,582
| New | +$27.7K |
|
471
Envoy Medical Warrant
COCHW
| $15.7K | ﹤0.01% |
236,254
-22,074
| -9% | -$1.18K |
|
|
GCTS.WS
472
GCT Semiconductor Holding Warrants
GCTS.WS
$17.6M
| $9.74K | ﹤0.01% |
53,845
-256,822
| -83% | -$37.3K |
|
|
ABPWW
473
DELISTED
Abpro Holdings Warrant
ABPWW
| $1.07K | ﹤0.01% |
358,427
| – | – |
|
|
ABX
474
Abacus Global Management
ABX
$988M
| – | – |
-119,267
| Closed | -$1.02M |
|
|
ALEX
475
DELISTED
Alexander & Baldwin
ALEX
| – | – |
-40,000
| Closed | -$826K |
|
Similar funds
GCP
GA
BAMG
VI
T
GAG
SCP
BHWM
Diametric Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Diametric Capital held 618 positions worth $385M, up 3.1% from $373M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Diametric Capital deployed $39.6M of net new capital in Q1 2026, opening 251 new positions and adding to 83 existing holdings. Its largest new stake was Forgent Power Solutions: 144,593 shares worth $4.23M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Harrow, an estimated $7.36M trimmed.
- Diametric Capital's largest Q1 2026 buy was Forgent Power Solutions: 144,593 shares worth $4.23M.
- Diametric Capital added most to Precigen in Q1 2026, an estimated $12.1M increase.
- Diametric Capital's biggest Q1 2026 reduction was Harrow, cutting an estimated $7.36M.
- Diametric Capital fully exited Red Rock Resorts in Q1 2026, selling an estimated $5.36M.
- Diametric Capital's ten largest holdings make up 20% of its $385M portfolio in Q1 2026.
- Diametric Capital opened 251 new positions and closed 145 in Q1 2026.
- Diametric Capital's portfolio value rose 3.1% quarter-over-quarter to $385M.
Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.